Abstract
Abstract 4-Phenyl-1-piperidinecarboxamide (AH 1932) markedly inhibits coughing induced in laboratory animals by chemical or mechanical irritation of the respiratory tract or by electrical stimulation of the superior laryngeal nerve. The compound is effective administered orally or parenterally and is at least as active as codeine. In contrast to codeine the antitussive activity of AH 1932 persists for 6 hr after oral administration. The evidence suggests a central site of action for AH 1932. The drug has a low acute toxicity in mice and rats, is devoid of analgesic activity, has no effect on the respiratory system and does not affect gastrointestinal propulsion. Cardiovascular effects are minimal. AH 1932 possesses weak spinal interneuron blocking activity unlikely to limit its use as a cough suppressant.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.